The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their ...

A large new study has shed light on the wider health impacts of taking Ozempic-style drugs. Weight-loss drugs like Ozempic ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Novo Nordisk’s NVO shares lost 5.3% on Friday after Medicare issued a press release selecting the company’s popular ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

You can fast, improve your sleep and diet your way to a flatter stomach. Here's how to lose belly fat without working out.

A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

While we’re unlikely to see a dramatic rise in deaths from vaccine-preventable diseases in the U.S. in the near term, the ...